Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

You are here: Home » Trials & Approvals

Trials & Approvals

Print

Updates on new clinical tirals being performed in China, trial updates and drug approvals...

Recent Articles

  Celltrion Approved to Start China Trials of Remicade Biosimilar
  Xiangxue Pharma Approved for China Trials of Brain Cancer Drug
  Xynomic Forms Partnership with UCSF for Cancer Drug Trial
  Uni-Bio Launches Oral Type 2 Diabetes Drug in China
  Yisheng Bio Starts China Phase I Trial of Immuno-Oncology Candidate
  Impact Therapeutics Granted CFDA Approval for China Test of PARP Inhibitor
  Sirnaomics OK'd to Start China Trial of siRNA Therapeutic
  CFDA Approves Venus Medtech's Minimally Invasive Aortic Valve Implant
  Bristol-Myers Squibb's Oral, Interferon-free HCV Regimen Approved in China
  Aslan Officially Announces $40 Million Taiwan IPO
 
Login